Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01605799 · ClinicalTrials.gov registry record · Phase 2
IOK Treatment Study
A Phase 2 study of Posttraumatic Stress Disorder, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT01605799 is a Phase 2 study of Posttraumatic Stress Disorder that has completed, run by VA Office of Research and Development. The registered enrollment target is 33 participants, below the 112-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01605799, a Phase 2 study of Posttraumatic Stress Disorder, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
The goals of this project are * 1\) to evaluate the effectiveness of a CBT treatment module addressing the mental health and functional impact of killing in the war zone, * 2\) to gather data on Veteran stakeholders' perceptions of acceptability and feasibility of the CBT treatment module, which would be used to further refine the intervention, and * 3\) to gather data on clinician stakeholders' perceptions of acceptability and feasibility of the CBT treatment module, which would be used to ensure that the module could be easily integrated into EBT for PTSD.
Conditions Studied
Interventions
- BEHAVIORAL IOK Killing Treatment
- BEHAVIORAL Wait list control group
Study Locations (1)
California
- San Francisco VA Medical Center, San Francisco, CA - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2012-10 |
| Est. Completion | 2015-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01605799
The ClinicalTrials.gov registry entry for NCT01605799 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 112-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (71% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Posttraumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which IOK Killing Treatment is the first listed.
NCT01605799 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01605799 about?
NCT01605799 is a clinical study titled "IOK Treatment Study". The goals of this project are * 1\) to evaluate the effectiveness of a CBT treatment module addressing the mental health and functional impact of killing in the war zone, * 2\) to gather data on Veteran stakeholders' perceptions of acceptability and feasibility of the CBT treatment module, which wo...
What is the current status of trial NCT01605799?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 33 participants. The study started on 2012-10. Estimated completion is 2015-01.
What conditions does trial NCT01605799 study?
This clinical trial studies the following conditions: Posttraumatic Stress Disorder.
What interventions are being tested in trial NCT01605799?
The interventions under investigation include: IOK Killing Treatment (BEHAVIORAL), Wait list control group (BEHAVIORAL).
Who is sponsoring clinical trial NCT01605799?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01605799 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Posttraumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Week-long Psychological Treatment for PTSD With Ketamine
RECRUITING · Phase 2
-
Ketamine, SGB and Combination Treatment for TBI
RECRUITING · Phase 2
-
Dose Optimization of MDMA-Assisted Therapy for PTSD
RECRUITING · Phase 2
-
Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD
RECRUITING · Phase 2
-
Pilot Study of the Safety and Efficacy of Four Different Potencies of Smoked Marijuana in 76 Veterans With PTSD
COMPLETED · Phase 2
-
Women Overcoming and Managing Adversity Now (WOMAN) Study
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.